Reasons why I have picked NOV:
- Fingers in many pies (also a negative, as distractions and if not done well increase risk)
- Willingness to innovate
- Ability to play with the 'big boys' (Afterpay, Marqueta, Bank Licence etc)
- None of the market segments are big enough to express dominance (yet) but we have all seen how growth can suddently explode once at critical mass (also a negative, as may never get there - and always bumble along)
- Founder still involved
Why I am still buying:
- Majority of Exec team / GMs etc been there a while and come either from internal promotion or solid external pedigre
- Senior team continue to demonstrate a willingness to 'muck in' and get stuff done - rather that just managing
- Cheap relative to most metrics
- Reckon. Every share I buy is 80% NOV, 20% Reckon which lowers relatively risk a little.
- Reckon. Cashflow.
What I don't like:
- Emersion - Struggled to grow. Purchased by NOV. Still struggling to grow with more staff = cash burn. Offload it.
- ATX - (Lack of) messaging / detail on how the business is going, and have not executed on any of the identified growth areas (expansion into Vietnam, lending).
- Messaging re: cashflow, GTV etc moves around to put spotlight on flavour of the month area. Undermines confidence.
- CEO comes across as too nice, and am concerned that doesn't have the brutal edge to make the tough decisions (e.g. cut staff to become cashflow +ve, offload Emersion if failing business etc)
- Forums
- ASX - By Stock
- NOV
- Novatti - The $1 party
Novatti - The $1 party, page-4267
Featured News
Add NOV (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $13.81M |
Open | High | Low | Value | Volume |
3.7¢ | 4.1¢ | 3.4¢ | $187.9K | 4.949M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 127555 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 127555 | 0.034 |
4 | 217935 | 0.033 |
8 | 525120 | 0.032 |
8 | 506731 | 0.031 |
10 | 1286467 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 150000 | 1 |
0.036 | 1300000 | 1 |
0.038 | 100000 | 1 |
0.039 | 442439 | 4 |
0.040 | 2343895 | 4 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NOV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online